Last edition
News about "mRNA seasonal flu vaccine"
GSK to Advance mRNA Seasonal Flu Vaccine Candidate to Phase 3
GSK advances its mRNA seasonal flu vaccine to phase 3 after positive phase 2 data showed higher immune responses versus standard and high-dose vaccines.
MRNA Seasonal Flu Vaccine | 02/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members